ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
What’s reshaping nuclear licensing and compliance today?
Mark Reidmeyer
It is the convergence of urgency, innovation, and modernization that is reshaping nuclear licensing and compliance today.
For decades, nuclear licensing operated in a relatively stable environment built around large light water reactors, predictable review cycles, and well-established regulatory pathways. Today, that model is evolving rapidly. Advanced reactors, AI-enabled tools, digital engineering platforms, grid reliability concerns, and aggressive decarbonization goals are all pushing the industry—and regulators—to move faster and think differently.
G. L. Woodruff, A. L. Babb, W. E. Wilson, Jr., Yuki Yamamoto, S. J. Stamm
Nuclear Technology | Volume 6 | Number 4 | April 1969 | Pages 352-359
Technical Papers and Note | doi.org/10.13182/NT69-A28344
Articles are hosted by Taylor and Francis Online.
A technique using neutron activation analysis has been developed for the early diagnosis of cystic fibrosis in children and infants. Toe- and finger-nail clippings from infants (under 1 month in age) and children (under 12 years of age) are collected in a prescribed manner and irradiated in a reactor. The irradiated samples are analyzed for Na, K, and Cl concentrations, and the patients having abnormally high values of Na and Cl are detected by computer sorting.